News
Emerging evidence points to potential benefits of continuous glucose monitoring (CGM) well beyond use as a management tool for people with diabetes who use insulin. Until recently, CGM use had ...
The following is a summary of “Evidence for improved glucose metrics and perinatal outcomes with continuous glucose ...
Continuous glucose monitoring devices could overstate blood sugar levels, with a study revealing inconsistencies in readings compared with traditional methods.
Scientists have identified a simple, noninvasive method for assessing blood glucose regulation using continuous glucose monitoring (CGM) data. Their approach, which tracks glucose fluctuations, ...
Senseonics Holdings Inc. advanced stock charts by Barron's. View SENS historical stock data and compare to other stocks, and exchanges.
The highs and lows of blood glucose aren't just an energy rollercoaster; they could be a key to detecting diabetes risk early ...
The Food and Drug Administration (FDA) has cleared the Dexcom G7 15 Day continuous glucose monitoring (CGM) system for ...
RUTHERFORD, N.J. and STOCKHOLM, April 03, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel ...
Morningstar brands and products Company Portfolio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results